IL-4 and HDAC Inhibitors Suppress Cyclooxygenase-2 Expression in Human Follicular Dendritic Cells.
- Author:
Whajung CHO
1
;
Seung Hee HONG
;
Jongseon CHOE
Author Information
- Publication Type:Brief Communication
- Keywords: Human; Stromal cells; Lipid mediator; Histone
- MeSH: Chromatin Assembly and Disassembly; Cyclooxygenase 2; Dendritic Cells, Follicular; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Interleukin-4; Lymphocytes; Monocytes; Prostaglandins; Stromal Cells; T-Lymphocytes
- From:Immune Network 2013;13(2):75-79
- CountryRepublic of Korea
- Language:English
- Abstract: Evidence for immunoregulatory roles of prostaglandins (PGs) is accumulating. Since our observation of PG production by human follicular dendritic cells (FDCs), we investigated the regulatory mechanism of PG production in FDC and attempted to understand the functions of released PGs in the responses of adjacent lymphocytes. Here, using FDC-like cells, HK cells, we analyzed protein expression alterations in cyclooxygenase-2 (COX-2) in the presence of IL-4 or histone deacetylase (HDAC) inhibitors. Both IL-4 and HDAC inhibitors suppressed COX-2 expression in dose-dependent manners. Their effect was specific to COX-2 and did not reach to COX-1 expression. Interestingly, HDAC inhibitors gave rise to an opposing effect on COX-2 expression in peripheral blood monocytes. Our results suggest that IL-4 may regulate COX-2 expression in FDCs by affecting chromatin remodeling and provide insight into the role of cellular interactions between T cells and FDC during the GC reaction. Given the growing interests in wide-spectrum HDAC inhibitors, the differential results on COX-2 expression in HK cells and monocytes raise cautions on their clinical use.
